Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Clear out junk files and repair common Windows errors3Scan for outdated or missing drivers - takes under a minuteThe reported MX$8,567.84 consensus target and 21.82% increase for Elevance Health are unverified in the available sources. A fact-check published October 5, 2026, could not substantiate either figure and did not identify the original analyst-data provider, the date of the estimate, or the earlier and later values behind the percentage change. That does not prove the figures were never published; it means the claim cannot currently be confirmed from the cited evidence.
Is the MX$8,567.84 target verified?
No. The October 5, 2026 fact-check by iTechGuides reports that it could not verify the target or the claimed increase. It also notes that the claim lacks an identified originating provider, an as-of date, and the before-and-after consensus values needed to check the calculation.
As an Amazon Associate I earn from qualifying purchases.
This is an evidence limitation, not proof the number never appeared anywhere. Without the original data or a traceable record of the calculation, the headline should not be treated as an established analyst estimate.
Free tools Windows power users keep installed
One-click scans. No signup required.
What do dated analyst snapshots show?
Third-party snapshots surfaced October 6, 2026, show a US-dollar consensus estimate, not confirmation of the peso-denominated claim. Their analyst coverage counts differ, underscoring that consensus varies with provider coverage and update timing.
#1 Best Overall
| Provider and snapshot | Listing and currency | Analyst count | Mean target | Target range | Last close |
|---|---|---|---|---|---|
| MarketScreener, surfaced October 6, 2026 | Elevance Health US listing; US dollars | 22 | $450.90 | $393–$492 | $394.51 |
| Bullstory, October 6, 2026 snapshot | Elevance Health US listing; US dollars | 21 | $450.90 | $393–$492 | not stated (Bullstory, October 6, 2026 snapshot) |
These are dated third-party snapshots and may change. The different analyst counts are a reason to name the provider and snapshot date when quoting consensus, rather than presenting one figure as a universal or company-issued target.
Is the Mexican-peso figure a share price or an analyst target?
They are different measures. MarketScreener’s Mexican S.E. page labels its MXN figure as an end-of-day quote and identifies the listing with the same issuer identifier; that is a share quote, not an analyst price target. It therefore cannot verify the claimed MX$8,567.84 consensus target. MarketScreener’s Mexican S.E. listing
Rank #2
How can the 21.82% increase be checked?
A percentage increase requires comparable earlier and later estimates. To validate this claim, a reader needs the originating provider’s record, its as-of date, and both consensus values used in the calculation. Those inputs are not identified in the available evidence, so the percentage cannot be independently recalculated without guessing.
Recommended Free Tools
For a meaningful comparison of analyst targets, align or disclose the following:
Rank #3
- The exact listing and ticker being analyzed.
- The currency used for the share quote and the target.
- The provider’s methodology and analyst coverage set.
- The snapshot or as-of date and the analyst count.
- The low-to-high target range, as well as the mean.
What company results provide context?
Elevance Health’s April 22, 2026 first-quarter release reported operating revenue of $49.5 billion, up 1.5% year over year, and adjusted diluted EPS of $12.58. The company raised its full-year 2026 adjusted diluted EPS guidance to at least $26.75. It also described elevated expected Medicaid medical-cost trend and anticipated membership declines in some lines. These are company-reported operating details, not confirmation of the disputed analyst-target headline. See the first-quarter 2026 results release.
“Our first quarter results exceeded expectations, reflecting underlying business strength and improving claims experience. We are raising our full-year adjusted EPS guidance, supported by greater visibility into the balance of the year. Our actions are driving more consistent performance and position Elevance Health for continued improvement over time.”
Gail K. Boudreaux, President and Chief Executive Officer of Elevance Health, April 22, 2026
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.Quick Recap
Bestseller No. 1Bestseller No. 2SaleBestseller No. 3Bestseller No. 4
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
